- Home
- BRCC vs AARD Comparison
BRCC vs AARD Comparison
Compare BRCC & AARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRCC
- AARD
- Stock Information
- Founded
- BRCC 2014
- AARD 2017
- Country
- BRCC United States
- AARD United States
- Employees
- BRCC N/A
- AARD N/A
- Industry
- BRCC Beverages (Production/Distribution)
- AARD Biotechnology: Pharmaceutical Preparations
- Sector
- BRCC Consumer Staples
- AARD Health Care
- Exchange
- BRCC Nasdaq
- AARD Nasdaq
- Market Cap
- BRCC 202.4M
- AARD 216.6M
- IPO Year
- BRCC N/A
- AARD 2025
- Fundamental
- Price
- BRCC $2.11
- AARD $9.35
- Analyst Decision
- BRCC Buy
- AARD Strong Buy
- Analyst Count
- BRCC 6
- AARD 4
- Target Price
- BRCC $4.70
- AARD $31.50
- AVG Volume (30 Days)
- BRCC 592.0K
- AARD 134.3K
- Earning Date
- BRCC 05-07-2025
- AARD 01-01-0001
- Dividend Yield
- BRCC N/A
- AARD N/A
- EPS Growth
- BRCC N/A
- AARD N/A
- EPS
- BRCC N/A
- AARD N/A
- Revenue
- BRCC $391,490,000.00
- AARD N/A
- Revenue This Year
- BRCC $5.91
- AARD N/A
- Revenue Next Year
- BRCC $11.60
- AARD N/A
- P/E Ratio
- BRCC N/A
- AARD N/A
- Revenue Growth
- BRCC N/A
- AARD N/A
- 52 Week Low
- BRCC $1.93
- AARD $6.79
- 52 Week High
- BRCC $7.14
- AARD $19.58
- Technical
- Relative Strength Index (RSI)
- BRCC 42.36
- AARD N/A
- Support Level
- BRCC $1.96
- AARD N/A
- Resistance Level
- BRCC $2.23
- AARD N/A
- Average True Range (ATR)
- BRCC 0.10
- AARD 0.00
- MACD
- BRCC 0.02
- AARD 0.00
- Stochastic Oscillator
- BRCC 51.79
- AARD 0.00
About BRCC BRC Inc.
BRC Inc is a veteran-controlled company that serves premium coffee, content, and merchandise to active military, veterans, and first responders. it is committed to producing great coffee that consumers love, and high-quality merchandise that enables its community to showcase its brand. its omnichannel distribution has three components: Direct to Consumer channel includes its e-commerce business, through which consumers order products online and products are shipped to them, Its wholesale channel includes products sold to an intermediary such as convenience, grocery, drug, and mass merchandise stores, who in turn sell those products to consumers, and Outpost channel includes revenue from its Company-operated and franchised Black Rifle Coffee retail coffee shop locations.
About AARD Aardvark Therapeutics Inc. Common Stock
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.